Dr. Evans is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Campus Dr
Unit 108
Scarborough, ME 04074Phone+1 207-303-3300Fax+1 207-250-2139
Education & Training
- Brown UniversityFellowship, Hematology and Medical Oncology, 2004 - 2007
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2000 - 2003
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2000
Certifications & Licensure
- FL State Medical License 2023 - Present
- OR State Medical License 2003 - Present
- ME State Medical License 2007 - 2026
- NH State Medical License 2007 - 2025
- RI State Medical License 2005 - 2007
- HI State Medical License 2003 - 2006
- MA State Medical License 2002 - 2006
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2013
Clinical Trials
- Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme Start of enrollment: 2012 Nov 01
Publications & Presentations
PubMed
- 14 citationsPPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study: BrUOG 244.Heinrich Elinzano, Michael Glantz, Maciej M. Mrugala, Santosh Kesari, David Piccioni
American Journal of Clinical Oncology. 2015-12-09 - 34 citationsPaclitaxel poliglumex, temozolomide, and radiation for newly diagnosed high-grade glioma: a Brown University Oncology Group Study.Suriya Jeyapalan, Jerrold L. Boxerman, John E. Donahue, Marc A. Goldman, Timothy J. Kinsella
American Journal of Clinical Oncology. 2014-10-01 - 34 citationsLapatinib/gemcitabine and lapatinib/gemcitabine/oxaliplatin: a phase I study for advanced pancreaticobiliary cancer.Howard Safran, Thomas J. Miner, Murray B. Resnick, Thomas A. DiPetrillo, Brendan McNulty
American Journal of Clinical Oncology. 2008-04-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: